Zemedy Application for Irritable Bowel Syndrome

Recruiting in Palo Alto (17 mi)

Overseen byLinda Nguyen, MD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Stanford University

No Placebo Group

Trial Summary

What is the purpose of this trial?The purpose of the study is investigate the effectiveness of Zemedy, a mobile application that enables the digital delivery of a CBT program to people with IBS.

Eligibility Criteria

This trial is for adults over 18 with Irritable Bowel Syndrome (IBS) who have had symptoms for at least 6 months. Participants must speak English, have been on a stable IBS treatment for 30 days, and own a smartphone to use the Zemedy app.

Inclusion Criteria

You must own a smartphone (iOS or Android) in order to participate in the CBT application.

I am 18 years old or older.

You can understand and communicate in English to use the application.

+2 more

Participant Groups

The study tests the effectiveness of Zemedy, a mobile app delivering cognitive behavioral therapy (CBT) programs to help manage IBS symptoms.

2Treatment groups

Experimental Treatment

Active Control

Group I: Experimental (TAU plus CBT)Experimental Treatment1 Intervention

Subjects who are in the Experimental Group will receive 8 weeks of CBT from the Zemedy mobile application in addition to their treatment as usual (TAU).

Group II: Control Group (TAU only)Active Control1 Intervention

Treatment as Usual (TAU) for IBS patients are tailored to each individual's needs and may involve treatment such as: dietary modification, exercise, medication, and anti-diarrheal therapy.